Literature DB >> 3358901

Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.

R A Robson1, J O Miners, D J Birkett.   

Abstract

Nine healthy male volunteers were studied to assess the possibility of an interaction between theophylline and nifedipine or verapamil using a randomised, crossover design. Subjects received theophylline 125 mg 8 hourly with and without nifedipine 20 mg 12 hourly and verapamil 80 mg 8 hourly. Nifedipine treatment reduced mean total theophylline clearance by 9%, due to decreased clearances via 1- and 3-demethylation. Verapamil treatment reduced mean total theophylline clearance by 14%, due to decreased clearances via 1- and 3-demethylation and 8-hydroxylation. Verapamil and nifedipine at usual clinical doses are unlikely to cause clinically significant changes in theophylline disposition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358901      PMCID: PMC1386365          DOI: 10.1111/j.1365-2125.1988.tb03319.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Increased serum theophylline concentrations secondary to oral verapamil.

Authors:  T G Burnakis; M Seldon; A D Czaplicki
Journal:  Clin Pharm       Date:  1983 Sep-Oct

2.  Comparison of theophylline and theobromine metabolism in man.

Authors:  D J Birkett; R Dahlqvist; J O Miners; A Lelo; B Billing
Journal:  Drug Metab Dispos       Date:  1985 Nov-Dec       Impact factor: 3.922

3.  The effect of oral verapamil therapy on antipyrine clearance.

Authors:  D O Rumiantsev; V K Piotrovskii; O S Riabokon; I D Slastnikova; E V Kokurina; V I Metelitsa
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

4.  Effect of nifedipine and theophylline in asthma.

Authors:  M Garty; E Cohen; A Mazar; D N Ilfeld; S Spitzer; J B Rosenfeld
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

5.  Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.

Authors:  L A Bauer; M Stenwall; J R Horn; R Davis; K Opheim; L Greene
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

6.  Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.

Authors:  D J Birkett; J O Miners; J Attwood
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

7.  Verapamil disposition--effects of sulphinpyrazone and cimetidine.

Authors:  L M Wing; J O Miners; K J Lillywhite
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

8.  The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.

Authors:  S H Jackson; K Shah; N M Debbas; A Johnston; C A Peverel-Cooper; P Turner
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

9.  Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction.

Authors:  G J Macphee; G T McInnes; G G Thompson; M J Brodie
Journal:  Lancet       Date:  1986-03-29       Impact factor: 79.321

  9 in total
  9 in total

1.  The effect of three different oral doses of verapamil on the disposition of theophylline.

Authors:  K A Stringer; J Mallet; M Clarke; J A Lindenfeld
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 4.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

5.  Nifedipine, verapamil and cyclosporin A pharmacokinetics in children.

Authors:  M R Ogborn; J F Crocker; P C Grimm
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

7.  Chronic cyclosporin A (CsA) nephrotoxicity in the rat: the effect of calcium blockade with verapamil.

Authors:  M G Shaikh; S D Heys; P A Brown; P H Whiting
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

8.  Felodipine reduces the absorption of theophylline in man.

Authors:  T Bratel; B Billing; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.

Authors:  R A Robson; E J Begg; H C Atkinson; D A Saunders; C M Frampton
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.